Cashu Logo
HomeWatchlistNewsSignalsPicks
DJI
+1.04%
SPX
+0.32%
IXIC
+0.14%
FTSE
+0.19%
N225
0.00%
AXJO
0.00%
Cashu Logo
Log In
HomeWatchlistNewsSignalsPicks
Stocks
0.00 (0.00%)
0.000
USD
At close at --,----
Cashu Logo Alt
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.

Company

  • About Us
  • Careers
  • Blog
  • News

Help & Support

  • Help Center
  • Contact Us
  • Pro Support

Legal

  • Privacy Policy
  • Terms of Use
InstagramYouTube

© 2024 Cashu PTY LTD.

Overview

Loading chart...
Join our newsletter to keep up to date with us!

About

What does SER do?
Serina Therapeutics, based in Alameda, California, is a clinical-stage biotechnology company developing drug candidates for neurological diseases, focusing on SER-252 for Parkinson's Disease. The company went public on November 29, 2018, and employs four people.
Sector
💻 Health Care
IPO
CEO
Employees
12
Headquarters
California, USA
Website
http://www.agexinc.com

Recently from Cashu

publisher logo
Cashu

AgeX Therapeutics: Adapting to Evolving Retirement Investment Trends Among Aging Investors

13 days ago
publisher logo
Cashu

AgeX Therapeutics: DNA&STONE's Innovative Strategies Propel Marketing Success and Social Change

18 days ago
publisher logo
Cashu

AgeX Therapeutics: DNA&STONE's Innovative Marketing and Commitment to Authenticity Recognized

20 days ago

Key Stats

Market Cap
54.42M
Dividend Yield
0.00%
P/E Ratio
-4.32
EPS
-4.88
Revenue
56.00K
Avg. Volume
11.86K
Stocks
Health Care
ser
AgeX Therapeutics
NYSE MKT LLC: SER
-0.09 (-1.74%)
5.365
USD
At close at Aug 13, 20:41 UTC
Summary
News
Signals
Benchmarks
Financials